Associated Papers
Mechanisms of resistance to RET-directed therapies.
Clifton-Bligh RJ
Endocrine-related Cancer, 2025
39655713 (PubMed )
Supplement: supplementary_materials.pdf
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.
Solomon BJ et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2020
31988000 (PubMed )
Supplement: NIHMS1616172-supplement-Supplementary_Data.docx
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.
Carlomagno F et al.
Endocrine-related Cancer, 2009
Select a paper to view details